Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection

THURSDAY, May 12, 2022 -- Patients with multidrug-resistant HIV-1 infection receiving the capsid inhibitor lenacapavir have a greater reduction in viral load than those receiving placebo, according to a study published in the May 12 issue of the New...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news